Austar Lifesciences Limited (HKG:6118)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
0.770
-0.030 (-3.75%)
Apr 28, 2026, 4:08 PM HKT
-1.28%
Market Cap 394.69M
Revenue (ttm) 1.70B
Net Income (ttm) 37.62M
Shares Out 512.58M
EPS (ttm) 0.07
PE Ratio 10.49
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 261,000
Average Volume 349,450
Open 0.800
Previous Close 0.800
Day's Range 0.750 - 0.800
52-Week Range 0.650 - 1.970
Beta 1.04
RSI 44.34
Earnings Date May 26, 2026

About Austar Lifesciences

Austar Lifesciences Limited, an investment holding company, engages in the provision of integrated engineering solutions to pharmaceutical manufacturers and research institutes in Mainland China and internationally. The company operates through Integrated Process and Packaging Equipment & Systems (IPS); Consulting, Digitalization and Construction (CDC); and Life Science Equipment and Consumables (SIC) segments. It also offers clean utility and bioprocess equipment, clean room, automation control and monitor system; bioprocess equipment consumab... [Read more]

Industry Medical Devices
Sector Healthcare
Founded 1991
Employees 1,468
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 6118
Full Company Profile

Financial Performance

In 2025, Austar Lifesciences's revenue was 1.53 billion, an increase of 2.02% compared to the previous year's 1.50 billion. Earnings were 33.81 million, an increase of 110.24%.

Financial numbers in CNY Financial Statements

News

There is no news available yet.